219 related articles for article (PubMed ID: 20100870)
1. Attracting AID to targets of somatic hypermutation.
Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
[TBL] [Abstract][Full Text] [Related]
2. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription.
Michael N; Shen HM; Longerich S; Kim N; Longacre A; Storb U
Immunity; 2003 Aug; 19(2):235-42. PubMed ID: 12932357
[TBL] [Abstract][Full Text] [Related]
3. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
4. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
[TBL] [Abstract][Full Text] [Related]
5. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
6. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
7. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
8. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID.
Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P
Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome stability dramatically impacts the targeting of somatic hypermutation.
Kodgire P; Mukkawar P; North JA; Poirier MG; Storb U
Mol Cell Biol; 2012 May; 32(10):2030-40. PubMed ID: 22393257
[TBL] [Abstract][Full Text] [Related]
10. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
[TBL] [Abstract][Full Text] [Related]
11. Somatic hypermutation of the AID transgene in B and non-B cells.
Martin A; Scharff MD
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
[TBL] [Abstract][Full Text] [Related]
12. Effects of aging on B cell function.
Frasca D; Blomberg BB
Curr Opin Immunol; 2009 Aug; 21(4):425-30. PubMed ID: 19608393
[TBL] [Abstract][Full Text] [Related]
13. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
14. E2A expression stimulates Ig hypermutation.
Schoetz U; Cervelli M; Wang YD; Fiedler P; Buerstedde JM
J Immunol; 2006 Jul; 177(1):395-400. PubMed ID: 16785535
[TBL] [Abstract][Full Text] [Related]
15. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
[TBL] [Abstract][Full Text] [Related]
16. AID preferentially targets the top strand in nucleosome sequences.
Singh AK; Jaiswal A; Kodgire P
Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting.
Dinesh RK; Barnhill B; Ilanges A; Wu L; Michelson DA; Senigl F; Alinikula J; Shabanowitz J; Hunt DF; Schatz DG
Eur J Immunol; 2020 Mar; 50(3):380-395. PubMed ID: 31821534
[TBL] [Abstract][Full Text] [Related]
18. AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.
Gramlich HS; Reisbig T; Schatz DG
PLoS One; 2012; 7(6):e39601. PubMed ID: 22768095
[TBL] [Abstract][Full Text] [Related]
19. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation.
Chatterji M; Unniraman S; McBride KM; Schatz DG
J Immunol; 2007 Oct; 179(8):5274-80. PubMed ID: 17911613
[TBL] [Abstract][Full Text] [Related]
20. Activation-induced cytidine deaminase (AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) protein SRSF1.
Kanehiro Y; Todo K; Negishi M; Fukuoka J; Gan W; Hikasa T; Kaga Y; Takemoto M; Magari M; Li X; Manley JL; Ohmori H; Kanayama N
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1216-21. PubMed ID: 22232677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]